Steven H. Stein

1.7k total citations
15 papers, 1.3k citations indexed

About

Steven H. Stein is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Steven H. Stein has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Genetics and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Steven H. Stein's work include HER2/EGFR in Cancer Research (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer Treatment and Pharmacology (4 papers). Steven H. Stein is often cited by papers focused on HER2/EGFR in Cancer Research (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer Treatment and Pharmacology (4 papers). Steven H. Stein collaborates with scholars based in United States, Netherlands and India. Steven H. Stein's co-authors include Michael Arbushites, Zeba Aziz, Henry Gómez, Cristina Oliva, Richard S. Finn, María Koehler, José Bines, Zanete Zvirbule, Judy Dering and Angelo Di Leo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Consulting and Clinical Psychology.

In The Last Decade

Steven H. Stein

15 papers receiving 1.3k citations

Peers

Countries citing papers authored by Steven H. Stein

Since Specialization

Citations

This map shows the geographic impact of Steven H. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven H. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven H. Stein more than expected).

Fields of papers citing papers by Steven H. Stein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven H. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven H. Stein. The network helps show where Steven H. Stein may publish in the future.

Co-authorship network of co-authors of Steven H. Stein

This figure shows the co-authorship network connecting the top 25 collaborators of Steven H. Stein. A scholar is included among the top collaborators of Steven H. Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven H. Stein. Steven H. Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	The signature program, a series of tissue-agnostic, mutation-specific signal finding trials. 2014 ·Journal of Clinical Oncology ·Eric D. Slosberg, Barinder Kang, J. Thaddeus Beck, Sarina A. Piha‐Paul, Robert J. Green, Donald Richards, Christopher L. Corless, Donald A. Berry, Steven H. Stein, August J. Salvado	2
2	HLA-DQA1 * 02:01 Is a Major Risk Factor for Lapatinib-Induced Hepatotoxicity in Women With Advanced Breast Cancer 2011 ·Journal of Clinical Oncology ·Colin F. Spraggs, (unknown), Linda P. Briley, Nan Bing, Charles Cox, Karen S. King, John C. Whittaker, Vincent Mooser, A. Preston, Steven H. Stein, Lon R. Cardon	199
3	A single-center experience of preemptive anticoagulation for patients with risk factors for allograft thrombosis in renal transplantation 2010 ·Clinical Nephrology ·Miho Murashima, Barbara A. Konkle, Roy D. Bloom, Suman L. Sood, Robert Grossman, Steven M. Brunelli, Steven H. Stein	22
4	Relationship of HLA-DQA10201* and lapatinib-induced hepatotoxicity in women with advanced breast cancer. 2010 ·Journal of Clinical Oncology ·Colin F. Spraggs, (unknown), Linda P. Briley, Nan Bing, A. Preston, Vincent Mooser, Lon R. Cardon, Steven H. Stein	1
5	Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens 2009 ·Annals of Oncology ·Kimberly Blackwell, Mark D. Pegram, Elizabeth Tan-Chiu, Lee S. Schwartzberg, Michael Arbushites, J. Maltzman, (unknown), S. D. Rubin, Steven H. Stein, Harold J. Burstein	136
6	5082 Lapatinib (L) plus capecitabine (C) in HER2+ metastatic breast cancer (MBC): exploratory analyses by prior therapy 2009 ·European Journal of Cancer Supplements ·John Crown, Michelle Casey, David Cameron, B. Newstat, Steven H. Stein	4
7	Phase III, Double-Blind, Randomized Study Comparing Lapatinib Plus Paclitaxel With Placebo Plus Paclitaxel As First-Line Treatment for Metastatic Breast Cancer 2008 ·Journal of Clinical Oncology ·Angelo Di Leo, Henry Gómez, Zeba Aziz, Zanete Zvirbule, José Bines, Michael Arbushites, (unknown), María Koehler, Cristina Oliva, Steven H. Stein, Lisa S. Williams, Judy Dering, Richard S. Finn, Michael F. Press	345
8	Efficacy and Safety of Lapatinib As First-Line Therapy for ErbB2-Amplified Locally Advanced or Metastatic Breast Cancer 2008 ·Journal of Clinical Oncology ·Henry Gómez, Dinesh Chandra Doval, Miguel A. Chavez, Peter Ang, Zeba Aziz, Shona Nag, Christina Ng, Sandra Franco, Louis W.C. Chow, Michael Arbushites, Michelle Casey, Mark S. Berger, Steven H. Stein, George W. Sledge	265
9	Lapatinib Antitumor Activity Is Not Dependent upon Phosphatase and Tensin Homologue Deleted on Chromosome 10 in ErbB2-Overexpressing Breast Cancers 2007 ·Cancer Research ·Wenle Xia, Intisar Husain, Lei-Hua Liu, Sarah Bacus, Shermini Saini, (unknown), Karen Pry, Ron E. Westlund, Steven H. Stein, Neil L. Spector	120
10	Results of an analysis of cardiac function in 2,812 patients treated with lapatinib 2006 ·Journal of Clinical Oncology ·EA Perez, Julie Byrne, Isaac W. Hammond, (unknown), (unknown), Marvin Berger, Tal Zaks, Cristina Oliva, D. Roychowdhury, Steven H. Stein	31
11	Determining relevant biomarkers from tissue and serum that may predict response to single agent lapatinib in trastuzumab refractory metastatic breast cancer 2005 ·Journal of Clinical Oncology ·(unknown), Harold J. Burstein, Mark D. Pegram, A. M. Storniolo, Vanessa Salazar, Janet Maleski, (unknown), Neil L. Spector, Steven H. Stein, M. S. Berger	56
12	Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura 2003 ·Journal of Clinical Apheresis ·Nicole A. Aqui, Steven H. Stein, Barbara A. Konkle, Charles S. Abrams, Frank J. Strobl	35
13	The Human Frontal Lobes: Functions and Disorders 2000 ·Archives of Clinical Neuropsychology ·Steven H. Stein	93
14	Arousal level in repressors and sensitizers as a function of response context. 1971 ·Journal of Consulting and Clinical Psychology ·Steven H. Stein	6
15	Conscious and Preconscious Influences on Recall: A Reassessment and Extension 1967 ·Psychological Reports ·Steven H. Stein, Robert H. Harrison	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact